Alpha-0261

DRUG3 trials

Sponsors

AlphaMol Science Ltd. (Shanghai), The First Affiliated Hospital of Anhui Medical University

Conditions

Chronic Spontaneous Urticaria (CSU)Healthy VolunteersUlcerative Colitis (UC)

Phase 1

A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers

CompletedNCT07279636

AlphaMol Science Ltd. (Shanghai)Healthy Volunteers

Start: 2025-07-21End: 2026-04-15Updated: 2026-06-30

Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).

Not yet recruitingNCT07684560

AlphaMol Science Ltd. (Shanghai)Chronic Spontaneous Urticaria (CSU), Healthy Volunteers

Start: 2026-07-01End: 2027-06-30Target: 48Updated: 2026-07-06

Alpha-0261 Tablets for Moderate-to-Severe Ulcerative Colitis

Not yet recruitingNCT07744646

The First Affiliated Hospital of Anhui Medical UniversityUlcerative Colitis (UC)

Start: 2026-08-03End: 2027-03-20Target: 10Updated: 2026-08-04